Abstract
Metastatic carcinoma presents a significant challenge in cancer treatment due to its aggressive nature and propensity for resistance to traditional therapeutic approaches. This systematic research paper delves into the development and evaluation of a novel combination chemotherapy regimen involving the use of 5-fluorouracil, cyclophosphamide & mitomycin C, and PHA skin test in the treatment of metastatic carcinoma, lymphomas, and breast cancer. The study aims to investigate the efficacy and safety profile of this combined chemotherapeutic approach, utilizing scientific methodology and analysis to assess its potential as a promising treatment option for patients with advanced cancer.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call